Application 084349

Type
ANDA
Sponsor
PARKE-DAVIS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001DILANTINPHENYTOIN SODIUMCAPSULE;ORAL30MG EXTENDEDNoYes
002DILANTINPHENYTOIN SODIUMCAPSULE;ORAL100MG EXTENDEDNoYes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A084349-001DILANTINPHENYTOIN SODIUM30MG EXTENDEDCAPSULE / ORALRLD, RS, Approved before 1982
A084349-002DILANTINPHENYTOIN SODIUM100MG EXTENDEDCAPSULE / ORALABRLD, RS, Approved before 1982

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A084349-002AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02A084349-001DILANTIN30MG EXTENDEDCAPSULE / ORALRLD, RS, Approved before 1982011fe1cb6892…
2026-02-19 14:30 UTC2026-02A084349-002DILANTIN100MG EXTENDEDCAPSULE / ORALABRLD, RS, Approved before 1982011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A084349-001DILANTIN30MG EXTENDEDCAPSULE / ORALRLD, RS, Approved before 198231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A084349-002DILANTIN100MG EXTENDEDCAPSULE / ORALABRLD, RS, Approved before 198231067a03dcf5…
2025-08-23 18:47 UTC2025-08A084349-001DILANTIN30MG EXTENDEDCAPSULE / ORALRLD, RS, Approved before 19826a471c1ec25d…
2025-08-23 18:47 UTC2025-08A084349-002DILANTIN100MG EXTENDEDCAPSULE / ORALABRLD, RS, Approved before 19826a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A084349-001DILANTIN30MG EXTENDEDCAPSULE / ORALRLD, RS, Approved before 1982fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A084349-002DILANTIN100MG EXTENDEDCAPSULE / ORALABRLD, RS, Approved before 1982fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A084349-001DILANTIN30MG EXTENDEDCAPSULE / ORALRLD, RS, Approved before 1982b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A084349-002DILANTIN100MG EXTENDEDCAPSULE / ORALABRLD, RS, Approved before 1982b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A084349-001DILANTIN30MG EXTENDEDCAPSULE / ORALRLD, RS, Approved before 198203ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A084349-002DILANTIN100MG EXTENDEDCAPSULE / ORALABRLD, RS, Approved before 198203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A084349-001DILANTIN30MG EXTENDEDCAPSULE / ORALRLD, RS, Approved before 19822680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A084349-002DILANTIN100MG EXTENDEDCAPSULE / ORALABRLD, RS, Approved before 19822680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A084349-001DILANTIN30MG EXTENDEDCAPSULE / ORALRLD, RS, Approved before 19825bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A084349-002DILANTIN100MG EXTENDEDCAPSULE / ORALABRLD, RS, Approved before 19825bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A084349-001DILANTIN30MG EXTENDEDCAPSULE / ORALRLD, RS, Approved before 1982d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A084349-002DILANTIN100MG EXTENDEDCAPSULE / ORALABRLD, RS, Approved before 1982d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A084349-001DILANTIN30MG EXTENDEDCAPSULE / ORALRLD, RS, Approved before 1982d06236e962d9…
2024-10-29 15:01 UTC2024-10A084349-002DILANTIN100MG EXTENDEDCAPSULE / ORALABRLD, RS, Approved before 1982d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A084349-001DILANTIN30MG EXTENDEDCAPSULE / ORALRLD, RS, Approved before 198279d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A084349-002DILANTIN100MG EXTENDEDCAPSULE / ORALABRLD, RS, Approved before 198279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A084349-001DILANTIN30MG EXTENDEDCAPSULE / ORALRLD, RS, Approved before 1982301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A084349-002DILANTIN100MG EXTENDEDCAPSULE / ORALABRLD, RS, Approved before 1982301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A084349-001DILANTIN30MG EXTENDEDCAPSULE / ORALRLD, RS, Approved before 19821e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A084349-002DILANTIN100MG EXTENDEDCAPSULE / ORALABRLD, RS, Approved before 19821e350fbaab3a…
2024-05-31 18:47 UTC2024-05A084349-001DILANTIN30MG EXTENDEDCAPSULE / ORALRLD, RS, Approved before 19828072bd15b7f6…
2024-05-31 18:47 UTC2024-05A084349-002DILANTIN100MG EXTENDEDCAPSULE / ORALABRLD, RS, Approved before 19828072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A084349-001DILANTIN30MG EXTENDEDCAPSULE / ORALRLD, RS, Approved before 19825c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A084349-002DILANTIN100MG EXTENDEDCAPSULE / ORALABRLD, RS, Approved before 19825c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A084349-001DILANTIN30MG EXTENDEDCAPSULE / ORALRLD, RS, Approved before 19825d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A084349-002DILANTIN100MG EXTENDEDCAPSULE / ORALABRLD, RS, Approved before 19825d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A084349-001DILANTIN30MG EXTENDEDCAPSULE / ORALRLD, RS, Approved before 19824b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A084349-002DILANTIN100MG EXTENDEDCAPSULE / ORALABRLD, RS, Approved before 19824b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A084349-001DILANTIN30MG EXTENDEDCAPSULE / ORALRS, Approved before 198274a2ff9319b5…
2019-12-13 00:20 UTC2019-12A084349-002DILANTIN100MG EXTENDEDCAPSULE / ORALABRS, Approved before 198274a2ff9319b5…
2022-03-09 01:35 UTC2022-03A084349-001DILANTIN30MG EXTENDEDCAPSULE / ORALRLD, RS, Approved before 1982bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03A084349-002DILANTIN100MG EXTENDEDCAPSULE / ORALABRLD, RS, Approved before 1982bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A084349-001DILANTIN30MG EXTENDEDCAPSULE / ORALRLD, RS, Approved before 1982782e0a99824c…
2021-12-28 21:50 UTC2021-12A084349-002DILANTIN100MG EXTENDEDCAPSULE / ORALABRLD, RS, Approved before 1982782e0a99824c…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02A084349-002AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A084349-002AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A084349-002AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A084349-002AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A084349-002AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A084349-002AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A084349-002AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A084349-002AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A084349-002AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A084349-002AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A084349-002AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A084349-002AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A084349-002AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A084349-002AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A084349-002AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A084349-002AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A084349-002AB14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A084349-002AB174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A084349-002AB1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A084349-002AB1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A084349-002AB187673890dc5c…
2021-03-12 10:30 UTC2021-03A084349-002AB15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A084349-002AB18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A084349-002AB1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A084349-002AB13f01610625f2…
2019-09-15 20:21 UTC2019-09A084349-002AB1b00525d2431f…
2019-07-19 19:46 UTC2019-07A084349-002AB1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A084349-002AB16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A084349-002AB11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A084349-002AB1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A084349-002AB1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A084349-002AB19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A084349-002AB1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A084349-002AB13f0d92c62455…
2023-05-13 08:27 UTC2023-05A084349-002AB1053a50430f4f…
2023-01-26 05:58 UTC2023-01A084349-002AB13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A084349-002AB13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A084349-002AB1f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A084349-002AB1e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A084349-002AB1cb3db0bc1861…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DILANTINEXTENDED PHENYTOIN SODIUMREMEDYREPACK INC.db8c69b0-4697-433e-98c7-b0b2d2c52a832025-10-02Warnings, Adverse reactionsExact identifier
application applno (ANDA): 084349
application number: ANDA084349
DILANTINEXTENDED PHENYTOIN SODIUMViatris Specialty LLC86dd27d1-9cee-48ae-b55d-e2d2f7dbc5932023-08-21Warnings, Adverse reactionsExact identifier
application applno (ANDA): 084349
application number: ANDA084349

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 22 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0071-0369DilantinExtended Phenytoin SodiumParke-Davis Div of Pfizer IncANDACurrent
0071-0369DilantinExtended Phenytoin SodiumParke-Davis Div of Pfizer IncANDACurrent
0071-0369DilantinExtended Phenytoin SodiumParke-Davis Div of Pfizer IncANDACurrent
0071-0369DilantinExtended Phenytoin SodiumParke-Davis Div of Pfizer IncANDACurrent
0071-0369DilantinExtended Phenytoin SodiumParke-Davis Div of Pfizer IncANDACurrent
0071-0369DilantinPhenytoin SodiumParke-Davis Div of PfizerANDACurrent
0071-0369DilantinExtended Phenytoin SodiumParke-Davis Div of Pfizer IncANDACurrent
0071-3740DilantinExtended Phenytoin SodiumParke-Davis Div of Pfizer IncANDACurrent
0071-3740DilantinExtended Phenytoin SodiumParke-Davis Div of Pfizer IncANDACurrent
0071-3740DilantinExtended Phenytoin SodiumParke-Davis Div of Pfizer IncANDACurrent
0071-3740DilantinExtended Phenytoin SodiumParke-Davis Div of Pfizer IncANDACurrent
0071-3740DilantinExtended Phenytoin SodiumParke-Davis Div of Pfizer IncANDACurrent
0071-3740DilantinPhenytoin SodiumParke-Davis Div of PfizerANDACurrent
0071-3740DilantinExtended Phenytoin SodiumParke-Davis Div of Pfizer IncANDACurrent
43353-131DilantinPhenytoin SodiumAphena Pharma Solutions - Tennessee, Inc.ANDACurrent
50090-0029DilantinPhenytoin SodiumA-S Medication SolutionsANDACurrent
50090-0029DilantinPhenytoin SodiumA-S Medication SolutionsANDACurrent
68151-1019DilantinPhenytoin SodiumCarilion Materials ManagementANDACurrent
69189-3742DilantinPhenytoin SodiumAvera McKennan HospitalANDACurrent
70518-0980DilantinPhenytoin SodiumREMEDYREPACK INC.ANDACurrent
70518-0980DilantinPhenytoin SodiumREMEDYREPACK INC.ANDACurrent
70518-0980DilantinPhenytoin SodiumREMEDYREPACK INC.ANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
72260SUPPL2022-10-06
72259SUPPL2022-10-06
69329SUPPL2021-11-16
69328SUPPL2021-11-16
64791SUPPL2020-10-02
64786SUPPL2020-10-01
57040SUPPL2018-12-27
57039SUPPL2018-12-27
51839SUPPL2018-01-26
51837SUPPL2018-01-26
51835SUPPL2018-01-26
48070SUPPL2017-04-19
39581SUPPL2015-04-23
31428SUPPL2015-04-23
39580SUPPL2014-07-29
39579SUPPL2014-03-06
39575SUPPL2014-03-06
9241SUPPL2014-03-06
9239SUPPL2014-03-06
39578SUPPL2013-09-19
9240SUPPL2013-08-08
31427SUPPL2012-12-06
39577SUPPL2012-11-30
43190SUPPL2012-03-28
39576SUPPL2011-05-06
39574SUPPL2009-10-19